Alvaro Avezum Selected Research

Acute Coronary Syndrome

6/2013	Acute coronary syndrome behavior: results of a Brazilian registry.
9/2011	Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007.
3/2011	Comparison between cardiac troponin I and CK-MB mass in acute coronary syndrome without st elevation.
10/2010	Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
9/2010	Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.
8/2009	Pulmonary artery catheterization in patients with acute coronary syndromes.
4/2009	Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
2/2009	Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
11/2008	Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
6/2008	Antithrombotics in acute coronary syndromes: actual guidelines and new evidences.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alvaro Avezum Research Topics

Disease

56	Stroke (Strokes) 12/2022 - 01/2005
36	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 04/2003
33	Myocardial Infarction 12/2022 - 02/2002
28	Hemorrhage 11/2022 - 07/2004
21	Acute Coronary Syndrome 06/2013 - 02/2002
18	Heart Failure 10/2022 - 02/2002
16	Hypertension (High Blood Pressure) 01/2022 - 08/2003
13	Atrial Fibrillation 01/2022 - 01/2005
11	Peripheral Arterial Disease 12/2022 - 05/2006
10	Diabetes Mellitus 01/2020 - 08/2003
10	ST Elevation Myocardial Infarction 01/2016 - 02/2002
9	Ischemic Stroke 05/2022 - 07/2012
9	Embolism (Embolus) 01/2021 - 03/2011
8	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 03/2005
8	Vascular Diseases (Vascular Disease) 01/2021 - 07/2009
7	COVID-19 06/2022 - 10/2020
7	Thrombosis (Thrombus) 06/2022 - 09/2010
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
5	Heart Arrest (Cardiac Arrest) 01/2021 - 10/2003
4	Obesity 01/2021 - 01/2015
4	Infarction (Infarctions) 10/2020 - 02/2005
4	Coronary Disease (Coronary Heart Disease) 12/2017 - 10/2011
3	Abdominal Obesity 01/2022 - 09/2004
3	Disease Progression 01/2021 - 07/2009
3	Brain Infarction 10/2020 - 08/2016
3	Cognitive Dysfunction 10/2020 - 01/2019
3	Unstable Angina 01/2018 - 07/2004
3	Chagas Cardiomyopathy 01/2016 - 07/2008
2	Hemorrhagic Stroke 01/2021 - 09/2011
2	Mitral Valve Stenosis (Mitral Stenosis) 01/2020 - 08/2015
2	Heart Valve Diseases (Valvular Heart Disease) 01/2018 - 08/2015
2	Body Weight (Weight, Body) 01/2018 - 01/2018
2	Neoplasms (Cancer) 05/2016 - 01/2015
2	Cataract (Cataracts) 05/2016 - 07/2012
2	Ventricular Tachycardia 10/2015 - 07/2008

Drug/Important Bio-Agent (IBA)

23	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 07/2004
15	RivaroxabanIBA 12/2022 - 01/2017
10	LipidsIBA 10/2022 - 09/2004
9	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2003
9	apixabanIBA 01/2018 - 03/2011
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 07/2004
8	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 09/2011
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2017 - 03/2003
6	CholesterolIBA 10/2022 - 03/2005
6	dulaglutideIBA 01/2022 - 01/2018
6	SodiumIBA 01/2021 - 01/2014
6	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 05/2016
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2004
5	ApolipoproteinsIBA 05/2022 - 09/2004
5	candesartanIBA 01/2021 - 05/2016
5	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 07/2004
5	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021 - 05/2016
5	Ramipril (Altace)FDA LinkGeneric 01/2020 - 03/2003
5	Pharmaceutical PreparationsIBA 01/2020 - 02/2009
5	CreatinineIBA 03/2011 - 10/2003
4	Enoxaparin (Lovenox)FDA LinkGeneric 12/2021 - 07/2004
4	PotassiumIBA 01/2021 - 11/2007
4	Telmisartan (Micardis)FDA Link 01/2020 - 07/2009
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2018
4	Vitamin K FDA Link 01/2020 - 03/2011
4	LDL CholesterolIBA 10/2017 - 08/2003
4	benzonidazole (benznidazole)IBA 01/2016 - 07/2008
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2011 - 03/2003
3	Blood Glucose (Blood Sugar)IBA 10/2022 - 02/2009
3	Apolipoproteins B (ApoB)IBA 05/2022 - 09/2004
3	Oxygen (Dioxygen)IBA 01/2021 - 10/2020
3	Insulin (Novolin)FDA Link 10/2020 - 11/2007
3	FatsIBA 11/2018 - 10/2017
3	Angiotensin Receptor AntagonistsIBA 12/2017 - 07/2009
3	Dabigatran FDA Link 07/2013 - 07/2012
2	oxidized low density lipoproteinIBA 05/2022 - 09/2007
2	HDL CholesterolIBA 01/2022 - 03/2005
2	fibrin fragment D (D-dimer)IBA 12/2021 - 01/2021
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2021
2	AntigensIBA 01/2021 - 07/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2017
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2020 - 10/2020
2	Azithromycin (Zithromax)FDA LinkGeneric 11/2020 - 10/2020
2	IncretinsIBA 01/2020 - 01/2018
2	AnticoagulantsIBA 01/2019 - 02/2015
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 01/2019
2	Proton Pump InhibitorsIBA 01/2019 - 01/2017
2	Pantoprazole (Protonix)FDA LinkGeneric 01/2019 - 01/2019
2	CarbohydratesIBA 11/2017 - 10/2017
2	C-Reactive ProteinIBA 10/2017 - 04/2003
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2017 - 05/2014
2	LDL Lipoproteins (beta Lipoproteins)IBA 05/2016 - 09/2007
2	EnzymesIBA 05/2014 - 10/2003

Therapy/Procedure

38	Therapeutics 06/2022 - 02/2002
14	Percutaneous Coronary Intervention 12/2016 - 11/2003
8	Secondary Prevention 01/2020 - 05/2006
7	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2016 - 01/2005
5	Stents 04/2015 - 02/2004
4	Long-Term Care 01/2019 - 01/2017
3	Subcutaneous Injections 01/2019 - 01/2018
3	Thrombectomy 01/2016 - 03/2014
3	Catheters 03/2014 - 08/2009
2	Surgical Amputation (Amputations) 01/2021 - 01/2020
2	Artificial Respiration (Mechanical Ventilation) 10/2020 - 10/2020
2	Heart Transplantation (Grafting, Heart) 10/2015 - 07/2008